Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Biocon chief Kiran...

    Biocon chief Kiran Shaw says it's a struggle to find adequate number of women for leadership roles

    Farhat NasimWritten by Farhat Nasim Published On 2019-02-23T10:00:17+05:30  |  Updated On 16 Aug 2021 5:32 PM IST

    "Over the next five to ten years we will hopefully see many more women playing leadership roles. Yes, things are happening but not at the pace that I want," Biocon Chief, Kiran Shaw said.


    MUMBAI: Biocon chairperson Kiran Mazumdar Shaw has lamented that she is struggling to find enough women to play leadership roles, even though there is a significant rise in their number in junior management roles.


    The comments come in the backdrop of the continuing calls for empowering and encouraging more women to take up leadership roles in companies and many other walks of life. This is reflected in the very low number of women on the board of companies.


    "Over the next five to ten years we will hopefully see many more women playing leadership roles. Yes, things are happening but not at the pace that I want," Shaw said without offering an explanation for the same in the sense that is it lack of adequate talent or the result of covert gender bias.


    Addressing the annual Nasscom leadership summit here on Friday, she also rued that regulations are not keeping pace with technological developments leaving companies unable to adopt them in smarter ways.


    Also Read: AstraZeneca joins hands with NASSCOM to address burden of NCDs in India



    "For many traditional businesses, the existential question is how do we embrace and leverage technology to secure our future. One of the reasons why traditional manufacturing industry hasn't really been very smart about adopting technology is because of regulations which haven't kept pace with what is happening in the technology world. This is our constant complaint and they are very very slow to move," she said.

    "So I think it's very important that companies are ahead of the curve and become strongly focused on how to leverage technology better," she added.


    Shaw admitted that setting up the Bengaluru-headquartered biopharmaceutical company was an uncalculated risk on her part as she was treading into uncharted territory.


    "My life and my journey have been about taking risks, most of them have been calculated risks. But the first risk that I embarked on was to start a biotech firm which was a completely uncalculated risk in many ways because I didn't know what I was getting into," she said.


    However, but once ventured into it there was no going back and she learned to the nuances of risk-taking, and understand the probability of success versus the risks.





    Observing that our culture prefers success and not risk-taking, she said, "I believe because we are culturally attuned to lower risks, we tend to focus on services rather than products. Products is high-risk and depending on the kind of innovation you start assessing what that risk is."


    Stating that she has taken risks with very high probability of success as well as with very low probability of success, she said "and many of the ones that had very low probabilities of success haven't worked. Maybe that's what I call failure."


    Also Read: 2 Biocon Bengaluru facilities undergo USFDA pre-approval inspection, One gets two observations



    BioconBiocon chairpersonBiocon Chiefbiocon newsIndia Business Newsjunior managementKiran Mazumdar ShawKiran Mazumdar Shaw newsNASSCOMwomen leadership
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok